Publication | Closed Access

Design, synthesis, and evaluation of resveratrol derivatives as Aß1–42 aggregation inhibitors, antioxidants, and neuroprotective agents

Medicinal ChemistryAß1–42 Aggregation InhibitorsBiochemistryMedicineNatural SciencesNeuroprotective AgentsResveratrol DerivativesNeuroprotectionPharmacologyPharmaceutical ChemistryDrug DiscoveryOxidative Stress